Biogen Pharmachem Industries Ltd Announces 1:6 Bonus Issue and Capital Increase

Biogen Pharmachem Industries Ltd, a company with CIN NO: L51100GJ1995PLC026702, has announced a series of decisions made during their board meeting held on 23rd March 2026. The board has approved an increase in the authorized share capital from Rs. 91,00,00,000 to Rs 1,08,00,00,000, subject to shareholder approval through a postal ballot. The board has also recommended altering the Capital Clause (Clause V) in the Memorandum of Association of the Company, subject to shareholder approval. The most significant announcement is the issuance of fully paid-up Bonus Shares in the ratio of 1:6, subject to shareholder approval. The company has also appointed M/s. Goenka Mehta & Associates Chartered Accountants, Rajkot as the new Statutory Auditors, subject to shareholder approval. The board has also approved the draft notice of Postal Ballot and the appointment of M/s Daxa Negi & Associates as the Scrutinizer for the Postal Ballot process.